FOR many of us, the covid-19 pandemic is fading into memory. But for millions of people, that isn’t possible as they are still unwell. An illness that is often brief and mild is, for some, the start of a rollercoaster of symptoms that can last years. Today, around 65 million people may have long covid….
Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment. This collaboration will capitalise on Absci’s Integrated Drug Creation platform—seamlessly integrating with AstraZeneca’s expertise in oncology, aiming to expedite the discovery of a potentially game-changing cancer therapy. Under the agreement,…
| Powered by WordPress | Theme by TheBootstrapThemes